Skip to content

Daily Upgrade Trial

TONE UP: Daily Upgrade Trial: Tone, Oxygenation, Neuromood, Energy - Upgrade Evaluation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07792603
Enrollment
44
Registered
2026-08-28
Start date
2026-08-31
Completion date
2027-04-01
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Women

Keywords

Dietary Supplement, Exercise training, Amino Acid, Body composition

Brief summary

This study evaluates the acute and chronic effects of an essential amino acid supplement (Daily Upgrade EAA+) on metabolomics, amino acid kinetics, metabolic rate, body composition in active adult women. The study consists of an acute randomized double-blind crossover phase comparing EAA+, whey protein isolate, and placebo before high-intensity interval training (HIIT), and a chronic randomized double-blind parallel-arm phase evaluating 3 weeks of EAA+ or placebo supplementation combined with twice-weekly HIIT.

Detailed description

The trial includes an acute crossover phase and a chronic parallel-group phase. In the acute phase, participants complete three randomized laboratory visits during which they consume Daily Upgrade EAA+, whey protein isolate, or a non-caloric placebo prior to a standardized high-intensity interval training (HIIT) session. Metabolomic responses, amino acid kinetics, metabolic outcomes are assessed before and after exercise. In the chronic phase, participants are randomized to consume Daily Upgrade EAA+ or placebo daily for three weeks while completing supervised HIIT sessions twice per week. Outcomes assessed before and after the intervention include body composition, exercise performance, fluid balance, and gastrointestinal symptoms.

Interventions

DIETARY_SUPPLEMENTEssential Amino Acid+

Daily supplementation of essential amino acids

DIETARY_SUPPLEMENTNon-Calorie Placebo

Daily supplementation with non-caloric placebo

BEHAVIORALHigh intensity Interval Training

Twice weekly high intensity interval training for 3 weeks

OTHERNo Exercise

No exercise

Sponsors

University of North Carolina, Chapel Hill
Lead SponsorOTHER
Sportiv, Inc.
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Intervention model description

This study incorporates two randomized intervention components within a single protocol. The primary trial is a double-blind, parallel-group study in which participants are randomized to receive either Daily Upgrade EAA+ or placebo during a 3-week supervised high-intensity interval training (HIIT) intervention. Embedded within the overall trial is an acute, randomized, double-blind crossover substudy in which a subset of participants completes three experimental visits and receives Daily Upgrade EAA+, whey protein isolate, and placebo in randomized order to evaluate acute metabolomic, metabolic, and physiological responses before and after HIIT.

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Participant is an adult between the ages of 25-45 years * Participant has a recorded BMI between 18.5-30 kg/m\^2 * Participant is apparently healthy and free from disease, as determined by a health history questionnaire * Participant is a biological female * Participant is naturally menstruating or uses a form of hormonal contraceptive * Participant is recreationally active, based on the International Physical Activity Questionnaire- Short Form * Participant agrees to abstain from caffeine (12 hours), tobacco, alcohol, and exercise for 24 hours prior to testing days * Participant is willing and able to comply with the protocol

Exclusion criteria

* Participant has been diagnosed with chronic heart disease, arrhythmias, thyroid disease, renal, hepatic, autoimmune or neurological diseases, as determined by a health history questionnaire. * Participant has a musculoskeletal disorder or injury that would prohibit them from being able to safely complete the study protocol. * Participant is currently enrolled in a separate clinical trial or weight loss program involving diet, exercise, physical activity, or the potential ingestion of an active drug or dietary supplement * Participant is using, or has consistently used one of the following dietary supplements within 1 month prior to enrollment: whey protein, creatine, essential amino acids * Participant has a known allergy or sensitivity to the placebo or active ingredients * Participant is pregnant or planning to become pregnant * Participant does not speak English or is hearing impaired

Design outcomes

Primary

MeasureTime frameDescription
Essential Amino Acid KineticsBaseline, 30, 60, and 90 minutes following supplementation during acute visits.Area under the curve for metabolomic responses
Substrate OxidationBefore (0 min) and after (30, 60, 90 min) one session of high intensity interval trainingRespiratory exchange ratio (RER)

Secondary

MeasureTime frameDescription
Lean Body MassBaseline and week 4Dual energy x-ray absorptiometry-derived lean soft tissue
Muscle sizeBaseline week 4Muscle cross sectional area derived from peripheral quantitative computed tomography
Fluid KineticsBaseline, week 1, week 2, week 3, week 4Total body water

Countries

United States

Contacts

CONTACTAbbie Smith-Ryan, PhD
abbiesmith@unc.edu919-962-2574
CONTACTResearch Coordinator
aplresearch@unc.edu919-962-1663
PRINCIPAL_INVESTIGATORAbbie Smith-Ryan, PhD

University of North Carolina, Chapel Hill

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026